Showing results (111-120 of 208) with videos related to
Sort By:
Pageof 21
Haematologica|October 16, 2012
Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphomaVincent Ribrag, Dolores Caballero, Christophe Fermé, et al.European Journal of Cancer (Oxford, England : 1990)|August 10, 2015
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal typeJean-Marie Michot, Renaud Mazeron, Alina Danu, et al.Cancer Research|February 7, 2007
Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartmentsYves Lepelletier, Valérie Camara-Clayette, Hulin Jin, et al.Cancer Medicine|September 21, 2022
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myelomaMaría Victoria Mateos, Felipe Prosper, Jesús Martin Sánchez, et al.British Journal of Haematology|March 25, 2016
A phase II, single-arm, multicentre study of coltuximab ravtansine (SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphomaBertrand Coiffier, Catherine Thieblemont, Sophie de Guibert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
A Phase II Study of Acimtamig (AFM13) in Patients with CD30-Positive, Relapsed, or Refractory Peripheral T-cell LymphomasWon Seog Kim, Jake Shortt, Pier Luigi Zinzani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly TrialEva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2018
Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular LymphomaFabienne Desmots, Mikaël Roussel, Céline Pangault, et al.Cancer Immunology, Immunotherapy : CII|July 24, 2020
Patterns of progression in patients treated for immuno-oncology antibodies combinationAlice Bernard-Tessier, Capucine Baldini, Eduardo Castanon, et al.Pageof 21